Status:
UNKNOWN
Prospective Randomized Trial of Irritative Symptoms Severity Assessment After (HoLEP) Versus ThuFLEP
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
BPH
Prostate Obstruction
Eligibility:
MALE
Phase:
NA
Brief Summary
The investigators hypothesize that the functional outcomes of both techniques are comparable. However, ThuFLEP might increase speed recovery of postoperative irritation and early stress urinary incont...
Detailed Description
Thulium fiber laser enucleation of the prostate (ThuFLEP) has already shown the outcomes comparable to OSP with better safety profile (lower blood loss compared to OSP) and shorter hospital stay. TFL ...
Eligibility Criteria
Inclusion
- LUTS presence, proven by:
- IPSS questionnaire (Score \>20);
- OR uroflowmetry result (Qmax \<10 ml/s);
Exclusion
- Prostate volume \> 120 cc
- Prostate cancer on pathology;
- Urethral strictures;
- Bladder calculi;
- Prior prostate surgery;
- Neurogenic bladder dysfunction.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 10 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04342533
Start Date
April 1 2020
End Date
October 10 2021
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, Russia, 119991